Clinical Trial Update: AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for AGuIX nanoparticles combined with radiotherapy and concomitant temozolomide in newly diagnosed glioblastoma; a Phase 1/2 study current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• AGuIX Nanoparticles (aguix nanoparticles)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Centre Jean Perrin | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING